Table 2.
Prevalence of major disease targets at baseline in the Korean genome and epidemiology study
| Characteristics | Population-based studiesd |
Gene-environment model studiese |
||||
|---|---|---|---|---|---|---|
| KoGES_Ansan and Ansung study | KoGES_HEXA | KoGES_CAVAS | KoGES_twin and family study | KoGES_ immigrant study | KoGES_ emigrant study | |
| n | 10030 | 173357 | 28338 | 3399 | 4786 | 3563 |
| Prevalence | ||||||
| Hypertension n (%)a | 3249 (33.88) | 50984 (30.98) | 12614 (40.10) | 645 (18.98) | 516 (10.78) | 1315 (36.91) |
| Type 2 diabetes n (%)b | 849 (8.76) | 15157 (9.35) | 3376 (10.29) | 228 (6.71) | 148 (3.09) | 264 (7.41) |
| Obesity n (%)c | 4290 (43.03) | 56857 (34.80) | 11295 (40.16) | 1070 (31.48) | 943 (19.70) | 1088 (30.54) |
aHypertension was defined as either a systolic or a diastolic blood pressure of ≥ 140 mmHg or ≥ 90 mmHg, respectively, or when participants self-reported the diagnosed diseases.
bType 2 diabetes was defined as either a fasting blood glucose level of ≥ 126 mg/dl or when participants self-reported the diagnosed diseases.
cObesity was defined as a body mass index ≥ 25 kg/m2.
dAge-standardized prevalence rate in population-based studies was based on the 2014 mid-year resident population data.
eCrude prevalence rates were shown for the gene-environment model studies due to lack of standard population data.